Jove
Visualize
联系我们

相关概念视频

Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

492
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
492
Study Design in Statistics01:15

Study Design in Statistics

7.8K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
7.8K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

180
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
180
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Extracting patient reported cannabis use and reasons for use from electronic health records: a benchmarking study of large language models.

medRxiv : the preprint server for health sciences·2026
Same author

Five Data-Informed Principles for Advancing Inclusive Research in Clinical Trials: A Pharma Perspective.

Advances in therapy·2025
Same author

R-index: a standardized representativeness metric for benchmarking diversity, equity, and inclusion in biopharmaceutical clinical trial development.

EClinicalMedicine·2025
Same author

Two-Layer Retrieval-Augmented Generation Framework for Low-Resource Medical Question Answering Using Reddit Data: Proof-of-Concept Study.

Journal of medical Internet research·2025
Same author

Investigating Data Diversity and Model Robustness of AI Applications in Palliative Care and Hospice: Protocol for Scoping Review.

JMIR research protocols·2024
Same author

Barriers to Clinical Trial Implementation Among Community Care Centers.

JAMA network open·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 4, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

POP-REFINE:在临床试验中评估和优化代表性的综合框架.

Corey M Benedum1, Somnath Sarkar2,3, Selen Bozkurt4

  • 1Genentech, Inc., South San Francisco, CA, USA.

Clinical pharmacology and therapeutics
|December 28, 2024
PubMed
概括

临床试验往往缺乏多样化的群体,导致健康不平等. 一个新的框架,人口优化,代表性评估和微调 (POREF),量化和提高试验代表性,以获得公平的治疗.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.2K

相关实验视频

Last Updated: Jun 4, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.2K

科学领域:

  • 临床试验方法论 临床试验方法论
  • 卫生公平研究 卫生公平研究
  • 生物统计学 生物统计学

背景情况:

  • 从历史上看,临床试验代表不同人群不足,延续了健康不平等.
  • 确保代表性对于治疗的适当性,对新疗法的公平获取以及研究结果的概括性至关重要.
  • 监管机构越来越多地关注新疗法在所有患者群体中的影响.

研究的目的:

  • 引入一个新的框架来量化和提高临床试验人群的代表性.
  • 为了解决测量和优化临床试验多样性的欠发达的系统方法.
  • 支持监管和内部决策流程,以实现更具包容性的临床研究.

主要方法:

  • 开发了人口优化,代表性评估和微调 (POREF) 框架.
  • 包括评估整体和子组代表性的方法.
  • 将框架应用于九项瘤学试验,使用非识别的电子健康记录数据库来量化符合条件的人口代表性.

主要成果:

  • 量化了九项瘤学临床试验的合格人群的代表性.
  • 证明了框架能够识别非代表性驱动因素的能力.
  • 展示了优化资格标准,以实现更具代表性的患者群体.

结论:

  • 该POREF框架提供了一个全面的,数据驱动的方法,以提高临床试验的代表性.
  • 这种系统方法可以提高研究结果的概括性,并减少营销后的差异.
  • 该框架可以适应各种疾病征兆,并且可以扩展到评估注册样本.